For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

Research

The New York Comprehensive Hemophilia Treatement Center has a rich history of research, both basic and clinical. Patients participate in single-center and multi-center trials of novel therapeutic agents, supported by the Clinical & Translational Science Center (CTSC) and overseen by the Institutional Review Board of Weill Cornell Medicine. 

Open Clinical Trials

Doctor Taking Blood

Research provides an opportunity for patients, families, physicians and scientists to better understand the rare diseases such as inherited bleeding disorders.  Participation in clinical trials help us to better understand, manage, and potentially to explore new treatments options.

We offer clinical trials that are that may be led by our center, or in collaboration with other institutions and pharmaceutical companies.

Clinical Studies

young male patient giving the doctor a high five

We offer participation in collaborative observational research studies to improve patient care and outcome.

Publications

Book with stethoscope on top

Publications highlighting the research and innovation from participating in research at our center.

Webinars and Educational Resources

Man smiling at computer

Education resources to better understand bleeding disorders.

Weill Cornell Connect

Weill Cornell Connect

Weill Cornell Connect is your patient portal that offers you personalized and secure online access to your medical records and the ability to manage your healthcare. Through Connect, you have access to test results, online appointments, communication with your provider’s office, and after-visit summaries.

Weill Cornell Medicine Comprehensive Hemophilia Treatment Center 525 East 68th Street
Payson 695
New York, NY 10065 Phone: (212) 746-3421 Fax: (212) 746-8609